These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1356443)

  • 1. Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.
    Moriyama K; Sasaki J; Matsunaga A; Arakawa F; Takada Y; Araki K; Kaneko S; Arakawa K
    Biochim Biophys Acta; 1992 Sep; 1128(1):58-64. PubMed ID: 1356443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound heterozygotes for a novel mutation, apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with severe type III hyperlipoproteinemia and familial hypercholesterolemia.
    Sakuma N; Hibino T; Saeki T; Nagata T; Sato T; Okuda N; Matsunaga A; Sasaki J
    J Atheroscler Thromb; 2014; 21(9):983-8. PubMed ID: 24953047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
    Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E-4Philadelphia (Glu13----Lys,Arg145----Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia.
    Lohse P; Mann WA; Stein EA; Brewer HB
    J Biol Chem; 1991 Jun; 266(16):10479-84. PubMed ID: 1674745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224 --> Gln) in a hyperlipidemic patient with xanthomatosis.
    Moriyama K; Sasaki J; Takada Y; Arakawa F; Matsunaga A; Ito Y; Arakawa K
    Biochim Biophys Acta; 1996 Jun; 1301(3):185-90. PubMed ID: 8664327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E2(Arg158----Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes.
    Weisgraber KH; Newhouse YM; Taylor JM; Tuan B; Nestruck AC; Davignon J; Mahley RW
    Arteriosclerosis; 1989; 9(1):50-7. PubMed ID: 2912421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygosity for apolipoprotein E-4Philadelphia(Glu13----Lys, Arg145----Cys) is associated with incomplete dominance of type III hyperlipoproteinemia.
    Lohse P; Rader DJ; Brewer HB
    J Biol Chem; 1992 Jul; 267(19):13642-6. PubMed ID: 1352296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a new apolipoprotein E variant (E2 Arg142-->Leu) in type III hyperlipidemia.
    Richard P; de Zulueta MP; Beucler I; De Gennes JL; Cassaigne A; Iron A
    Atherosclerosis; 1995 Jan; 112(1):19-28. PubMed ID: 7772063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping.
    Walden CC; Huff MW; Leiter LA; Connelly PW; Hegele RA
    J Clin Endocrinol Metab; 1994 Mar; 78(3):699-704. PubMed ID: 7907341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
    Feussner G; Albanese M; Mann WA; Valencia A; Schuster H
    Eur J Clin Invest; 1996 Jan; 26(1):13-23. PubMed ID: 8682150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of hyperlipidemia with homozygous apolipoprotein E5 (Glu3-->Lys).
    Kobayashi J; Shirai K; Murano T; Misawa Y; Tashiro J; Yoshida T; Shinomiya M
    Biochim Biophys Acta; 2002 Jun; 1583(1):117-21. PubMed ID: 12069856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apo E variants in patients with type III hyperlipoproteinemia.
    Civeira F; Pocoví M; Cenarro A; Casao E; Vilella E; Joven J; González J; Garcia-Otín AL; Ordovás JM
    Atherosclerosis; 1996 Dec; 127(2):273-82. PubMed ID: 9125318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
    Weisgraber KH; Rall SC; Innerarity TL; Mahley RW; Kuusi T; Ehnholm C
    J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
    Kobori S; Nakamura N; Uzawa H; Shichiri M
    Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
    Rall SC; Weisgraber KH; Innerarity TL; Bersot TP; Mahley RW; Blum CB
    J Clin Invest; 1983 Oct; 72(4):1288-97. PubMed ID: 6313758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein epsilon 2/3 genotype and type III hyperlipoproteinemia among Taiwanese.
    Lin HP; Kao JT
    Clin Chim Acta; 2003 Apr; 330(1-2):173-8. PubMed ID: 12636937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.
    Ando M; Sasaki J; Hua H; Matsunaga A; Uchida K; Jou K; Oikawa S; Saito T; Nihei H
    Kidney Int; 1999 Oct; 56(4):1317-23. PubMed ID: 10504484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.
    Rall SC; Newhouse YM; Clarke HR; Weisgraber KH; McCarthy BJ; Mahley RW; Bersot TP
    J Clin Invest; 1989 Apr; 83(4):1095-101. PubMed ID: 2539388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136-->Ser) variant in multigenerational pedigree studies.
    Pocovi M; Cenarro A; Civeira F; Myers RH; Casao E; Esteban M; Ordovas JM
    Atherosclerosis; 1996 Apr; 122(1):33-46. PubMed ID: 8724110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.